Intravenously injectable immune serum globulin

Details Intravenously injectable immune serum globulin Intravenously injectable immune serum globulin

1983-04-18

1985-02-12

Shapiro, Lionel M.

Drug, bio-affecting and body treating compositions

Lymphokine

424101, 514 21, 260112B, 260112R, A23J 106, A61K 3935, A61K 3704, C07G 700

Patent

active

044990731

ABSTRACT:
A composition is disclosed which comprises a solution in a pharmaceutically acceptable carrier of an immune serum globulin, said solution having an ionic strength and a pH to maintain the monomer content and the actual and latent anticomplement activity of the immune serum globulin such that the composition is intravenously injectable. Novel methods are disclosed for preparing the above composition.

REFERENCES:
patent: 4082734 (1978-04-01), Stephan
patent: 4093606 (1978-06-01), Coval
patent: 4136094 (1979-01-01), Condie
patent: 4168303 (1979-09-01), Nishida et al.

Affiliated with

Also associated with

Rating

Intravenously injectable immune serum globulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intravenously injectable immune serum globulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenously injectable immune serum globulin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1389029